Yayın Ağı
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
80
8. Two cases with homozygous TACI mutation; could TACI mutation be a cause of microcephaly and growth retardation?
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, ss.825-826, (Özet Bildiri)
9. Autoimmune and inflammatory diseases in primary immune deficiencies
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, ss.828-829, (Özet Bildiri)
10. Cerebral ischemic attacks in ADA2 deficiency treated with adalimumab
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, ss.828, (Özet Bildiri)
11. LRBA deficiency in three patients, single center experience
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portekiz, 1 - 05 Haziran 2019, ss.825, (Özet Bildiri)
22. Coexistence of Lymphoproliferative Syndrome, Neurofibromatosis, Systemic Lupus Erythematosus and Hyper IgM Syndrome in a Patient with MSH6 Mutation
Annual Meeting of the Clinical-Immunology-Society (CIS) / Immune Deficiency and Dysregulation North American Conference, Georgia, Amerika Birleşik Devletleri, 4 - 07 Nisan 2019, (Özet Bildiri) 
29. Vedolizumab treatment in patient with XLA, is it safe and efficient?
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Almanya, 26 - 30 Mayıs 2018, ss.768-769, (Özet Bildiri)
30. SOTI to cow's milk in 3 cases with anaphylaxis after cow's milk consumption
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Almanya, 26 - 30 Mayıs 2018, ss.502-503, (Özet Bildiri)
31. Omalizumab treatment in childhood chronic urticaria
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Almanya, 26 - 30 Mayıs 2018, ss.227, (Özet Bildiri)